United Kingdom· GB-APID-24608011000001103
Striverdi Respimat 2.5micrograms/dose inhalation solution cartridge with device
A olodaterol product containing olodaterol, registered in United Kingdom by Boehringer Ingelheim Ltd. The same ATC class is registered in 14 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Olodaterol is registered in 14 of 19 countries.
Countries holding a registration under ATC R03AC19 (olodaterol), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 9 of them publish a price we can compare per daily dose
Olodaterol · ATC R03AC19
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of olodaterol costs, country by country.
Normalised to the WHO defined daily dose (5 mcg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Olodaterol · price per daily dose (5 mcg)
USD · FX 28 Sept 2026
- CH Switzerland$1.64
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Olodaterol
- Manufacturer
- Boehringer Ingelheim Ltd
- Country
- United Kingdom (GB)
- ATC code
- R03AC19
- ATC class
- Olodaterol
- Defined daily dose
- 5 mcg, Inhal
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin5012816099142
- gtin05012816081246
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
386 interactions on record for olodaterol.
Graded by severity as the source publishes them — 20 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Olodaterol · interactions on record
386 records
- 20 severe
- 365 moderate
- 1 minor
Most severe, free to view
- PindololC07AA03severe
- PropranololC07AA05severe
- TimololC07AA06severe
- SotalolC07AA07severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Olodaterol in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsStriverdi Respimat 2,5 microgram, inhalatieoplossingBoehringer Ingelheim International GmbH
- SwitzerlandStriverdi Respimat 2.5 mcg, Lösung zur Inhalation (wiederverwendbar)Boehringer Ingelheim (Schweiz) GmbH
- FinlandStriverdi RespimatBoehringer Ingelheim International GmbH
- IrelandStriverdi Respimat 2.5 microgram inhalation solutionBoehringer Ingelheim International GmbH
- NorwayStriverdi RespimatBoehringer Ingelheim International GmbH
- PolandStriverdi RespimatBoehringer Ingelheim International GmbH
- BelgiumStriverdi Respimat 2.5 µgBoehringer Ingelheim International
- SwedenStriverdi Respimat 2,5 mikrogram per puff Inhalationsvätska, lösningBoehringer Ingelheim International GmbH
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Striverdi Respimat
- Belgium · Striverdi Respimat
- Bulgaria · Стриверди Респимат
- Cyprus · Striverdi Respimat
- Czechia · Striverdi Respimat
- Germany · Striverdi Respimat
- Denmark · Striverdi Respimat
- Estonia · Striverdi Respimat
- Spain · Striverdi Respimat
- Finland · Striverdi Respimat
- France · Striverdi Respimat
- Greece · Striverdi Respimat
- Hungary · Striverdi Respimat
- Ireland · Striverdi Respimat
- Iceland · Striverdi Respimat
- Italy · Striverdi Respimat
- Liechtenstein · Striverdi Respimat
- Lithuania · Striverdi Respimat
- Luxembourg · Striverdi Respimat
- Latvia · Striverdi Respimat
- Malta · Striverdi Respimat
- Netherlands · Striverdi Respimat
- Norway · Striverdi Respimat
- Poland · Striverdi Respimat
- Portugal · Striverdi Respimat
- Romania · Striverdi Respimat
- Sweden · Striverdi Respimat
- Slovenia · Striverdi Respimat
- Slovakia · Striverdi Respimat
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cde686ee-a3b9-4df5-9f52-ee9c1d5c137e GET /v1/drugs/cde686ee-a3b9-4df5-9f52-ee9c1d5c137e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "24608011000001103",
"desc": "Striverdi Respimat 2.5micrograms/dose inhalation solution cartridge with device (Boehringer Ingelheim Ltd)",
"form": "Inhalation solution",
"vpid": "24670111000001108",
"source": "dmd",
"vtm_id": "776983009",
"strength": "2.5 microgram",
"substance": "Olodaterol",
"ingredient": "Olodaterol hydrochloride",
"supplier_code": "2065401000001103"
}See everything about olodaterol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.